The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3-Reference-Cited by-同舟云学术

The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3

Published:1991-07 Issue:2 Volume:66 Page:395-403
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Klein Rüdiger,Nanduri Venkata,Jing Shuqian,Lamballe Fabienne,Tapley Peter,Bryant Sherri,Cordon-Cardo Carlos,Jones Kevin R.,Reichardt Louis F.,Barbacid Mariano

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference38 articles.

1. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septa] cholinergic neurons in culture;Alderson;Neuron,1990

2. The trk family of tyrosine protein kinase receptors;Barbacid;Biochim. Biophys. Acta Rev. Cancer,1991

3. Purification of a new neurotrophic factor from mammalian brain;Barde;EMBO J.,1982

4. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3;Cordon-Cardo;Cell,1991

5. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain;Ernfors,1990

Cited by 855 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social complexity during early development has long-term effects on neuroplasticity in the social decision-making network;2024-08-30

2. The BDNF/TrkB pathway in Somatostatin-expressing neurons suppresses cocaine-seeking behaviour;2024-08-12

3. The Role of Central and Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker of Anorexia Nervosa Reconceptualized as a Metabo-Psychiatric Disorder;Nutrients;2024-08-08

4. Pyrazolo[1,5-a]pyrimidine as a Prominent Framework for Tropomyosin Receptor Kinase (Trk) Inhibitors—Synthetic Strategies and SAR Insights;Molecules;2024-07-29

5. Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease;Pharmaceuticals;2024-07-28